Lyndra Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 82

Employees

  • Latest Deal Type
  • Out of Business

Lyndra Therapeutics General Information

Description

Developer of novel therapeutics designed to sustain extended drug release in an oral dosage form. The company is engaged in the development of oral ultra-long-acting and sustained-release therapies for broad applicability across multiple therapeutic areas, including approved drugs, enabling the medical community to ensure improved medication adherence and health outcomes and helping lower the cost of care.

Contact Information

Website
www.lyndra.com
Formerly Known As
Lyndra
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 65 Grove Street
  • Suite 301
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 65 Grove Street
  • Suite 301
  • Watertown, MA 02472
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lyndra Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Out of Business 25-Mar-2025 Completed Out of Business
13. Later Stage VC (Series E) 21-Dec-2023 Completed Clinical Trials - Phase 3
12. Later Stage VC (Series D) 07-Jun-2023 Completed Clinical Trials - Phase 2
11. Secondary Transaction - Private 03-May-2022 Completed Clinical Trials - Phase 2
10. Later Stage VC (Series C) 23-Jun-2021 Completed Clinical Trials - Phase 2
9. Grant 01-Jun-2021 Completed Clinical Trials - Phase 2
8. Grant 01-Jan-2020 Completed Clinical Trials - Phase 2
7. Grant 30-Sep-2019 Completed Clinical Trials - Phase 2
6. Grant 30-Jul-2019 $13M $84.4M Completed Startup
5. Early Stage VC (Series B) 11-Feb-2019 $60.9M $84.4M Completed Clinical Trials - Phase 2
To view Lyndra Therapeutics’s complete valuation and funding history, request access »

Lyndra Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 21,961,511 $0.001000 6% $1.08 $1.08 1x $1.08 17.28%
To view Lyndra Therapeutics’s complete cap table history, request access »

Lyndra Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics designed to sustain extended drug release in an oral dosage form. The company is engaged
Drug Discovery
Watertown, MA
82 As of 2025

Orth An Der Donau, Austria
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lyndra Therapeutics Competitors (14)

One of Lyndra Therapeutics’s 14 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Manufacturing Austria Corporation Orth An Der Donau, Austria
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Gilead Sciences Formerly VC-backed Foster City, CA
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 14 competitors. Get the full list »

Lyndra Therapeutics Patents

Lyndra Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240398701-A1 Manufacturing methods for gastric residence systems Pending 02-Jun-2023
AU-2023354428-A1 Risperidone dosage regimens with gastric residence systems Pending 30-Sep-2022
EP-4565274-A2 Metal cores for gastric residence systems Pending 03-Aug-2022
AU-2023209872-A1 Dosage forms for gastric retention Pending 19-Jan-2022
EP-4465964-A2 Dosage forms for gastric retention Pending 19-Jan-2022 A61K9/0065
To view Lyndra Therapeutics’s complete patent history, request access »

Lyndra Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lyndra Therapeutics Investments (1)

Lyndra Therapeutics’s most recent deal was a Joint Venture with Lyndra (China) Pharmaceuticals Company. The deal was made on 01-May-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lyndra (China) Pharmaceuticals Company 01-May-2018 Joint Venture Pharmaceuticals
To view Lyndra Therapeutics’s complete investments history, request access »

Lyndra Therapeutics FAQs

  • When was Lyndra Therapeutics founded?

    Lyndra Therapeutics was founded in 2015.

  • Where is Lyndra Therapeutics headquartered?

    Lyndra Therapeutics is headquartered in Watertown, MA.

  • What is the size of Lyndra Therapeutics?

    Lyndra Therapeutics has 82 total employees.

  • What industry is Lyndra Therapeutics in?

    Lyndra Therapeutics’s primary industry is Drug Discovery.

  • Is Lyndra Therapeutics a private or public company?

    Lyndra Therapeutics is a Private company.

  • What is Lyndra Therapeutics’s current revenue?

    The current revenue for Lyndra Therapeutics is .

  • How much funding has Lyndra Therapeutics raised over time?

    Lyndra Therapeutics has raised $288M.

  • Who are Lyndra Therapeutics’s competitors?

    Pfizer Manufacturing Austria, ACADIA Pharmaceuticals, Intas Pharmaceuticals, Gilead Sciences, and Pfizer Pakistan are some of the 14 competitors of Lyndra Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »